mp.weixin.qq.com·· 14 hours agoPickScore85
China Phase 3 briGHt Subgroup: Weekly Lonapegsomatropin Beat Daily GH by 1.26 cm/Year in Ages 3-6 GHD
In brief
Visen Pharma reported a subgroup analysis of the China Phase 3 briGHt study. In children with GHD aged 3-6 years, 52 weeks of once-weekly lonapegsomatropin produced an annualized height velocity 1.26 cm/year higher than a daily growth hormone formulation.
Why it matters
Subgroup results stratified by baseline age report AHV, Ht SDS and p values for comparing weekly versus daily growth hormone.
Source: mp.weixin.qq.com · mp.weixin.qq.com